Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Myocardial Infarction and ADCY9[original query] |
|---|
| ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control Study. JAMA cardiology 2018 Mar . Nissen Steven E, Pillai Sreekumar G, Nicholls Stephen J, Wolski Kathy, Riesmeyer Jeffrey S, Weerakkody Govinda J, Foster Wendra M, McErlean Ellen, Li Lin, Bhatnagar Pallav, Ruotolo Giacomo, Lincoff A Micha |
| Impact of ADCY9 Genotype on Response to Anacetrapib. Circulation 2019 7 140 (11): 891-8. Hopewell Jemma C, Ibrahim Maysson, Hill Michael, Shaw Peter M, Braunwald Eugene, Blaustein Robert O, Bowman Louise, Landray Martin J, Sabatine Marc S, Collins Rory, |
| Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib. American heart journal 2020 2 222 157-165. Tardif Jean-Claude, Dubé Marie-Pierre, Pfeffer Marc A, Waters David D, Koenig Wolfgang, Maggioni Aldo P, McMurray John J V, Mooser Vincent, White Harvey D, Heinonen Therese, Black Donald M, Guertin Marie-Claude, |
| Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial. European heart journal 2022 Jul . Tardif Jean Claude, Pfeffer Marc A, Kouz Simon, Koenig Wolfgang, Maggioni Aldo P, McMurray John J V, Mooser Vincent, Waters David D, Grégoire Jean C, L'Allier Philippe L, Wouter Jukema J, White Harvey D, Heinonen Therese, Black Donald M, Laghrissi-Thode Fouzia, Levesque Sylvie, Guertin Marie Claude, Dubé Marie Pierre, |
- Page last reviewed:Feb 1, 2024
- Content source:

